Top

Journal of Thrombosis and Thrombolysis

Published in:

01-08-2020 | Disseminated Intravascular Coagulation | Letter to the Editor

Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy

Authors: F. Burcu Belen-Apak, F. Sarıalioğlu

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2020

Excerpt

To the editor, …

Thachil J (2020) The versatile heparin in COVID-19. J Thromb Haemost. https://doi.org/10.1111/jth.14821 CrossRefPubMedPubMedCentral

Tang N, Li D, Wang X, Sun Z (2020 Apr) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847. https://doi.org/10.1111/jth.14768 CrossRefPubMedPubMedCentral

Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844–847. https://doi.org/10.1111/jth.14768 CrossRefPubMedPubMedCentral

McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C (2020) Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated Intravascular coagulation. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2020.102537 CrossRefPubMedPubMedCentral

Fox SE, Akmatbekov A, Harbert JL, Li G, Brown Q, Vander Heide RS (2020) Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. MedRxiv. https://doi.org/10.1101/2020.04.06.20050575 CrossRefPubMedPubMedCentral

Tian S, Hu W, Niu L, Liu H, Xu H, Xiao Y (2020) Pulmonary pathology of early-phase, 2019 novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. https://doi.org/10.1016/j.jtho.2020.02.010 CrossRefPubMedPubMedCentral

Moore H, Barrett CD, Moore EE, McIntyre RC, Moore PK, Talmar DS, Moore FA, Yaffe MB (2020) Is there a role for plasminogen activator (tPA) as a novel treatment for refractory COVID-19 associated with acute respiratory distress syndrome (ARDS)? J Trauma Acute Care Surg. https://doi.org/10.1097/TA.0000000000002694 CrossRefPubMedPubMedCentral

Wu T, Wang T, Guo C, Zhang D, Ge X, Huang Z, Zhou X, Li Y, Peng Q, Li J (2020) Plasminogen improves lung lesions and hypoxemia in patients with COVID-19. QJM. https://doi.org/10.1093/qjmed/hcaa121 CrossRefPubMedPubMedCentral

Pescador R, Capuzzi L, Mantovani M, Fulgenzi A, Ferrero ME (2013) Defibrotide: properties and clinical use of an old/new drug. Vascul Pharmacol 59:1–10. https://doi.org/10.1016/j.vph.2013.05.001 CrossRefPubMed

Title: Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy
Authors: F. Burcu Belen-Apak
F. Sarıalioğlu
Publication date: 01-08-2020
Publisher: Springer US
Keywords: Disseminated Intravascular Coagulation
Tissue Plasminogen Activator
Fibrinolytic Therapy
Acute Respiratory Distress-Syndrome
COVID-19
Low Molecular Weight Heparin
Published in: Journal of Thrombosis and Thrombolysis / Issue 2/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02129-0

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy

Excerpt

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel

Deep vein thrombosis: a less noticed complication in hematologic malignancies and immunologic disorders

Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life

Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page